Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
BACKGROUND
Multiple sclerosis (MS) is the most common cause of chronic neurologic disability beginning in early to middle adult life. Results from recent genome-wide association studies (GWAS) have substantially lengthened the list of disease loci and provide convincing evidence supporting a multifactorial and polygenic model of inheritance. Nevertheless, the knowledge of MS genetics remains incomplete, with many risk alleles still to be revealed.


METHODS
We used a discovery GWAS dataset (8,844 samples, 2,124 cases and 6,720 controls) and a multi-step logistic regression protocol to identify novel genetic associations. The emerging genetic profile included 350 independent markers and was used to calculate and estimate the cumulative genetic risk in an independent validation dataset (3,606 samples). Analysis of covariance (ANCOVA) was implemented to compare clinical characteristics of individuals with various degrees of genetic risk. Gene ontology and pathway enrichment analysis was done using the DAVID functional annotation tool, the GO Tree Machine, and the Pathway-Express profiling tool.


RESULTS
In the discovery dataset, the median cumulative genetic risk (P-Hat) was 0.903 and 0.007 in the case and control groups, respectively, together with 79.9% classification sensitivity and 95.8% specificity. The identified profile shows a significant enrichment of genes involved in the immune response, cell adhesion, cell communication/signaling, nervous system development, and neuronal signaling, including ionotropic glutamate receptors, which have been implicated in the pathological mechanism driving neurodegeneration. In the validation dataset, the median cumulative genetic risk was 0.59 and 0.32 in the case and control groups, respectively, with classification sensitivity 62.3% and specificity 75.9%. No differences in disease progression or T2-lesion volumes were observed among four levels of predicted genetic risk groups (high, medium, low, misclassified). On the other hand, a significant difference (F = 2.75, P = 0.04) was detected for age of disease onset between the affected misclassified as controls (mean = 36 years) and the other three groups (high, 33.5 years; medium, 33.4 years; low, 33.1 years).


CONCLUSIONS
The results are consistent with the polygenic model of inheritance. The cumulative genetic risk established using currently available genome-wide association data provides important insights into disease heterogeneity and completeness of current knowledge in MS genetics.
Department of Neurology, University of California San Francisco, San Francisco, CA 94143-0435, USA. jorge.oksenberg@ucsf.edu.
Joanne H
JH
Wang
Derek
D
Pappas
Philip L
PL
De Jager
Daniel
D
Pelletier
Paul Iw
PI
de Bakker
Ludwig
L
Kappos
Chris H
CH
Polman
Lori B
LB
Chibnik
David A
DA
Hafler
Paul M
PM
Matthews
Stephen L
SL
Hauser
Sergio E
SE
Baranzini
Jorge R
JR
Oksenberg
Hum Mol Genet. 2006 Sep 15;15(18):2813-24
16905561
Ann Neurol. 2010 Jan;67(1):3-10
20186855
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7
19380721
Mult Scler. 2009 Jun;15(6):661-7
19482860
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5264-9
19237575
Ann Neurol. 2007 Mar;61(3):228-36
17252545
N Engl J Med. 2007 Aug 30;357(9):851-62
17660530
Neurology. 2007 Jan 30;68(5):376-83
17261686
Nature. 2003 Dec 18;426(6968):789-96
14685227
Brain. 2009 Jan;132(Pt 1):250-9
19022862
Nat Rev Genet. 2008 Jul;9(7):516-26
18542080
Mult Scler. 2005 Oct;11(5):504-10
16193885
Genome Res. 2007 Oct;17(10):1537-45
17785539
Arch Neurol. 2008 Mar;65(3):337-44
18195134
Am J Hum Genet. 1990 Feb;46(2):222-8
2301392
Brain. 2008 Dec;131(Pt 12):3118-31
18490360
Nat Genet. 2009 Jul;41(7):824-8
19525955
Prog Neurobiol. 2008 Dec 11;86(4):368-78
18930111
Ann Neurol. 2007 Jun;61(6):504-13
17492755
Neurogenetics. 2009 Feb;10(1):5-11
18843511
Nat Genet. 2007 Nov;39(11):1329-37
17952073
Nature. 2006 Oct 5;443(7111):574-7
17006452
Lancet. 2008 Oct 25;372(9648):1502-17
18970977
Lancet Neurol. 2008 Jul;7(7):567-9
18565446
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18680-5
19846760
Hum Mol Genet. 2007 Oct 15;16(20):2494-505
17666406
Genome Biol. 2003;4(5):P3
12734009
PLoS One. 2009;4(2):e4565
19242548
Hum Mol Genet. 2009 Feb 15;18(4):767-78
19010793
BMC Bioinformatics. 2004 Feb 18;5:16
14975175
Lancet Neurol. 2009 Dec;8(12):1111-9
19879194
Nat Genet. 2009 Jul;41(7):776-82
19525953
Am J Hum Genet. 1998 Jul;63(1):252-8
9634526
Hum Mol Genet. 2009 Jun 1;18(11):2078-90
19286671
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12877-82
14569025
Ann Neurol. 2007 Apr;61(4):288-99
17444504
Genes Immun. 2006 Jun;7(4):310-5
16625214
Nature. 2009 Aug 6;460(7256):748-52
19571811
Neurology. 2005 Apr 12;64(7):1144-51
15824338
PLoS One. 2009 Jul 20;4(7):e6309
19617918
Lancet Neurol. 2009 Mar;8(3):280-91
19233038
Arch Neurol. 2009 Aug;66(8):972-8
19667218